DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prozac (Fluoxetine Hydrochloride) - Published Studies

 
 



Prozac Related Published Studies

Well-designed clinical trials related to Prozac (Fluoxetine)

Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial. [2015]

Comparable efficacy and safety of 8 weeks treatment with agomelatine 25-50mg or fluoxetine 20-40mg in Asian out-patients with major depressive disorder. [2014]

Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial. [2014]

A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. [2014]

Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism. [2014]

Augmentation of fluoxetine with lovastatin for treating major depressive disorder, a randomized double-blind placebo controlled-clinical trial. [2013]

Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study. [2013]

L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine. [2013]

Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode. [2013]

Pharmacokinetic evaluation of olanzapine + fluoxetine for the treatment of bipolar depression. [2013]

12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder. [2012]

Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis. [2012]

Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. [2012]

A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. [2012]

A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder. [2011.12]

Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders. [2011.11.22]

The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. [2011.10]

Personality predictors of antiaggressive response to fluoxetine: inverse association with neuroticism and harm avoidance. [2011.09]

Listening to fluoxetine: a hot message from the FLAME trial of poststroke motor recovery. [2011.08]

Fluoxetine as a treatment for post-traumatic stress disorder. [2011.07]

Response rates to fluoxetine in subjects who initially show no improvement. [2011.07]

Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression. [2011.04]

A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients. [2011.04]

The relevance between symptoms and magnetic resonance imaging analysis of the hippocampus of depressed patients given electro-acupuncture combined with Fluoxetine intervention - A randomized, controlled trial. [2011.03]

Amisulpride vs. fluoxetine treatment of chronic fatigue syndrome: a pilot study. [2011.03]

Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse. [2011.02]

Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. [2011.02]

Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram? [2011.01]

Fluoxetine treatment of alcoholic perpetrators of domestic violence: a 12-week, double-blind, randomized, placebo-controlled intervention study. [2011.01]

Listening to fluoxetine: a hot message from the FLAME trial of poststroke motor recovery. [2011]

Residual symptoms after remission of major depressive disorder with fluoxetine and risk of relapse. [2011]

A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients. [2011]

Fluoxetine treatment of alcoholic perpetrators of domestic violence: a 12-week, double-blind, randomized, placebo-controlled intervention study. [2011]

Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. [2010.11.01]

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study. [2010.11]

Technical note: Effects of rumen passage on fluoxetine bioavailability in serum and effects of fluoxetine on serum prolactin concentration and demeanor in ewes. [2010.11]

Comparative bioavailability and tolerability of a single 20-mg dose of two fluoxetine hydrochloride dispersible tablet formulations in fasting, healthy Chinese male volunteers: an open-label, randomized-sequence, two-period crossover study. [2010.10]

Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome. [2010.07.01]

Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up. [2010.07]

Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. [2010.07]

Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome. [2010.07]

Fluoxetine treatment of alcoholic perpetrators of domestic violence: a 12-week, double-blind, randomized, placebo-controlled intervention study. [2010.06.29]

Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression. [2010.05]

Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder. [2010.03.17]

Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. [2010.03]

Effects of venlafaxine and fluoxetine on lymphocyte subsets in patients with major depressive disorder: a flow cytometric analysis. [2010.02.01]

Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients. [2010.01.30]

Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. [2010.01]

Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an indian population perspective. Retrospective pharmacokinetic data evaluation. [2010]

Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up. [2010]

Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies. [2010]

Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. [2010]

Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder. [2010]

Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. [2010]

Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients. [2010]

Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. [2010]

Influence of electro-acupuncture on the side effects of fluoxetine on depression patients. [2009.12]

A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder. [2009.11.13]

Randomized, controlled clinical trial of the efficacy of fluoxetine for treatment of compulsive disorders in dogs. [2009.09.15]

A randomized double-blind clinical trial on analgesic efficacy of fluoxetine for persistent somatoform pain disorder. [2009.09.04]

Efficacy evaluation for depression with somatic symptoms treated by electroacupuncture combined with Fluoxetine. [2009.09]

Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. [2009.09]

Homeopathic Individualized Q-potencies versus Fluoxetine for Moderate to Severe Depression: Double-blind, Randomized Non-inferiority Trial. [2009.08.17]

Combination of acupuncture and fluoxetine for depression: a randomized, double-blind, sham-controlled trial. [2009.08]

Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico. [2009.08]

Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. [2009.07]

A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. [2009.05]

Fluoxetine treatment for anxiety in women undergoing in vitro fertilization. [2009.05]

A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. [2009.04.21]

Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling. [2009.04]

The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial. [2009.03.19]

Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients. [2009.03.17]

A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). [2009.03]

A randomized controlled clinical trial of Citalopram versus Fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). [2009.02.03]

Fluoxetine and imipramine: are there differences in cost-utility for depression in primary care? [2009.02]

Single dose of fluoxetine increases muscle activation in chronic stroke patients. [2009.01]

Suicidality in a placebo-controlled fluoxetine study of body dysmorphic disorder. [2009.01]

Cost-effectiveness and cost-utility of cognitive therapy, rational emotive behavioral therapy, and fluoxetine (Prozac) in treating depression: a randomized clinical trial. [2009.01]

A double-masked, placebo-controlled study of fluoxetine for hypochondriasis. [2008.12]

Effects of the selective serotonin reuptake inhibitor fluoxetine on counterregulatory responses to hypoglycemia in individuals with type 1 diabetes. [2008.12]

Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers. [2008.11]

Treating thermally injured children suffering symptoms of acute stress with imipramine and fluoxetine: a randomized, double-blind study. [2008.11]

Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder. [2008.10.30]

The effects of citalopram and fluoxetine on sexual behavior in healthy men: evidence of delayed ejaculation and unaffected sexual desire. A randomized, placebo-controlled, double-blind, double-dummy, parallel group study. [2008.10]

A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. [2008.09]

Effects of a selective serotonin reuptake inhibitor, fluoxetine, on counterregulatory responses to hypoglycemia in healthy individuals. [2008.09]

Effects of fluoxetine on disease activity in relapsing multiple sclerosis: a double-blind, placebo-controlled, exploratory study. [2008.09]

The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depression. [2008.09]

Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. [2008.06.15]

Treatment of depression and anxiety in infertile women: cognitive behavioral therapy versus fluoxetine. [2008.05]

Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. [2008.04]

[Assessment of effectiveness of electroacupuncture and fluoxetine for treatment of depression with physical symptoms] [2008.03]

Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder. [2008.03]

Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: A randomized, open-label, 12-week, parallel-group trial. [2008.02.15]

Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. [2008]

Fluoxetine improves the quality of life in patients with poststroke emotional disturbances. [2008]

Effect of folic acid combined with fluoxetine in patients with major depression on plasma homocysteine and vitamin B12, and serotonin levels in lymphocytes. [2008]

Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. [2008]

SET-C versus fluoxetine in the treatment of childhood social phobia. [2007.12]

A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. [2007.11]

Comparisons of glucose-insulin homeostasis following maprotiline and fluoxetine treatment in depressed males. [2007.11]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017